Toronto Innovation Acceleration Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4

- Investments
-
70
- Portfolio
-
33
- Exits
-
28

Toronto Innovation Acceleration Partners General Information
Description
MaRS Innovation is a non-profit venture capital investment firm that acts on behalf of their members-14 of Toronto's top universities, institutions and research institutes, plus the MaRS Discovery District-to bring their most promising research breakthroughs to market. The firm specializes in extreme early-stage seed investing for companies and emerging technologies. The firm is based in Toronto, Canada and was founded in 2008.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Not-For-Profit Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
- MaRS Centre, West Tower
- 661 University Avenue, Suite 465
- Toronto, Ontario M5G 1M1
- Canada
+1 (647) 000-0000
Toronto Innovation Acceleration Partners Investments (70)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Radiant Biotherapeutics | 25-Apr-2023 | Seed Round | 000 | Drug Discovery | Generating Revenue | |
000000 00000000000 | 26-Sep-2022 | 0000 00000 | 00.00 | Biotechnology | Pre-Clinical Trials | |
000000000 | 01-Sep-2021 | 0000 00000 | 00.000 | Medical Records Systems | Generating Revenue | |
0000000 0000000000 | 22-Dec-2020 | 000000000000 | 00000 | Drug Discovery | Generating Revenue | |
000000 00000 00000 | 03-Dec-2019 | 0000 00000 | Drug Discovery | Pre-Clinical Trials | 000000 000000000 | |
00000 000000000000 | 01-Nov-2019 | 0000 00000 | 00.000 | Drug Discovery | Generating Revenue | |
00000000 00000000 | 02-Apr-2019 | 00000 | 0000 | Drug Delivery | Generating Revenue | |
000 0000000 | 24-Apr-2018 | 00000 | 0000 | Therapeutic Devices | Generating Revenue | |
bridge7 | 01-Jan-2018 | Accelerator/Incubator | 00000 | Outcome Management (Healthcare) | Out of Business | |
Deep Genomics | 14-Aug-2017 | Early Stage VC | 0000 | Discovery Tools (Healthcare) | Pre-Clinical Trials |
Toronto Innovation Acceleration Partners Exits (28)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Kaypok | 03-Apr-2023 | Out of Business | |
000 0000 0000000 | 20-May-2022 | 000 00 00000000 | |
0000000 | 01-Jan-2022 | 000 00 00000000 | |
000 00000000000 | 01-Sep-2021 | 000 00 00000000 | |
000000000000000 | 01-Jul-2021 | 000 00 00000000 | |
00 00000000 | 20-May-2021 | 000000000000000000 | 00000 |
0000000000 | 31-Dec-2020 | 000 00 00000000 | |
00000000 | 17-Nov-2020 | 000000 0000000000 | 000.00 |
CoHealth | 28-Oct-2020 | Merger/Acquisition | |
Forbius | 21-Sep-2020 | Merger/Acquisition |
Toronto Innovation Acceleration Partners Investments by Industry, Year, and Region
Toronto Innovation Acceleration Partners Team (13)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Lincoln Kim | Senior Director | Toronto, Canada | |||
Parimal Nathwani | Vice President, Life Sciences | 0 | 0 | Toronto, Canada | |
Greg Pruner | Advisor | Toronto, Canada |
Toronto Innovation Acceleration Partners Co-Investors (18)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Lumira Ventures | 3 | 0 |
![]() |
![]() |
|
Alexandria Venture Investments | 0 |
![]() |
![]() |
||
GreenSky Ventures | 0 | 0 |
![]() |
![]() |
|
Schrödinger | 0 | 0 |
![]() |
![]() |
|
Sunnybrook Health Sciences Centre | 0 |
![]() |
![]() |